Question 1

What does Symbiotec Pharmalab Limited do?

Accepted Answer

Symbiotec Pharmalab Limited operates in API products, CDMO services, and complex injectables, generating revenue through science and fermentation capabilities. Price band ₹938.00-₹988.00; issue size ₹1757.00 cr.

Question 2

When does the SYMBIOTEC PHARMALAB LIMITED IPO open and close?

Accepted Answer

The SYMBIOTEC PHARMALAB LIMITED IPO opens for subscription on August 24, 2026 and closes on August 27, 2026. Shares are expected to list on September 1, 2026.

Question 3

What is the issue price of the SYMBIOTEC PHARMALAB LIMITED IPO?

Accepted Answer

The SYMBIOTEC PHARMALAB LIMITED IPO was priced at ₹988 per equity share.

Question 4

What is the lot size for the SYMBIOTEC PHARMALAB LIMITED IPO?

Accepted Answer

The lot size is 15 equity shares. At ₹988 per share, one lot requires ₹14,820.

Question 5

What is the issue size of the SYMBIOTEC PHARMALAB LIMITED IPO?

Accepted Answer

The total issue size is ₹1,757.00 crore. This comprises a fresh issue of ₹150.00 crore, which the company receives, and an offer for sale of ₹1,607.00 crore, which goes to selling shareholders.

Question 6

How did Symbiotec Pharmalab Limited perform on listing?

Accepted Answer

Symbiotec Pharmalab Limited opened at ₹988 against an issue price of ₹988, a premium of 0.00% on debut.

Question 7

Who are the lead managers for the SYMBIOTEC PHARMALAB LIMITED IPO?

Accepted Answer

The book running lead managers are JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited and Nomura Financial Advisory and Securities (India) Private Limited. The registrar to the issue is MUFG Intime India Private Limited.

Company
Symbiotec Pharmalab LimitedThis Issue	—	—	₹869.15 Cr	₹19.00	₹184.69	9.48%
Concord Biotech Limited	₹1,513.4	61.07x	₹1.05K Cr	₹24.78	—	14.00%
Divi's Laboratories Limited	₹8,495	87.80x	₹10.56K Cr	₹96.75	₹631.00	16.50%
Cohance Lifesciences Limited	₹444.7	95.02x	₹2.27K Cr	₹4.68	—	7.00%
Laurus Labs Limited	₹1,799	109.36x	₹6.81K Cr	₹16.45	—	16.80%

Symbiotec Pharmalab Limited

Issue Timeline & Lifecycle

Subscription Demand

Fundamentals & Key Metrics

Valuation & Multiples

Profitability & Returns

Financial Health & Solvency

Financials at a glance

Shareholding, Ownership & Dilution

Disclosed Pre-Offer Shareholders Table

AI Summary

Prospectus Research

Issue intermediaries

Listed Peer Valuation & Returns

Official Prospectus Filings

Frequently Asked Questions